Biliary Stents Market Size By Type (Metal Stents, Polymer Stents), By Application (Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), By End-use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), COVID-19 Impac

Biliary Stents Market Size By Type (Metal Stents, Polymer Stents), By Application (Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), By End-use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032


Biliary Stents Market is expected to grow massively through 2032, owing to the rising prevalence of gallstones and several biliary disorders that contribute significantly to the growing demand for minimally invasive procedures. According to a National Institute of Diabetes and Digestive and Kidney Diseases report, over 60 million Americans suffer from gastrointestinal disorders, claiming approximately 250,000 lives each year. That said, rising cognizance around gastrointestinal disease diagnosis and treatment would further foster the market expansion in the coming years.

Another pivotal factor supporting the industry outlook includes growing investments in R&D, new product launches, and mergers, acquisitions, and partnerships by leading behemoths to reinforce their presence in the marketplace.

Overall, the biliary stents market is segmented in terms of product, application, end-use, and region.

Based on product, the metal stent segment is anticipated to showcase lucrative growth through 2032. Optimum benefits offered by metal stents, such as better patency, minimal slippage post-placement, and a longer lifecycle, are further anticipated to stimulate the product adoption in the coming years. Besides, metal stents enhance blood flow through the artery, avert heart attacks, and improve symptoms such as shortness of breath and chest pain. All these factors are anticipated to propel segmental expansion in the future.

Considering the application, the pancreatic cancer segment is anticipated to demonstrate massive growth during 2023-2032. The growth is likely to come from the rising cases of pancreatic cancer worldwide, as a result of alcohol abuse and tobacco consumption. Pancreatic cancer is a refractory malignancy and is the 7th primary cause of cancer deaths globally in industrialized countries and the third most common in the USA.

On the basis of end-use, the ambulatory surgical centers segment is slated to demonstrate sturdy growth. This can be credited to several advantages offered by ambulatory care, which include lowered costs, fast recovery, and lower rates of infection. Besides, the mounting prevalence of minimally invasive procedures and increased healthcare expenditure across the globe are slated to drive the segmental expansion in the near future.

Regionally, the Asia Pacific biliary stents market is anticipated to exhibit massive growth during the forecast period. The growth can be ascribed to the large population base and a strong patient pool across various economies. In addition, the constant advancements taking place in the healthcare infrastructure in developing countries in the Asia Pacific are slated to propel market expansion in the future.